Keyphrases
Nicotinic Agonists
100%
Ventral Hippocampus
100%
Attentional Set-shifting
100%
Tetrodotoxin
100%
Schizophrenia
40%
Nucleus Accumbens
40%
Nicotinic Acetylcholine Receptor (nAChR)
40%
Postnatal Day
40%
Prefrontal Cortex
40%
Extradimensional Shift
40%
Therapeutic Potential
20%
Initial Acquisition
20%
Systemic Administration
20%
Symptom Cluster
20%
Attentional Set-shifting Task
20%
Dysregulation
20%
Initial Ability
20%
Ability to Learn
20%
Dorsal Hippocampus
20%
Number of Trials
20%
Cognitive Effects
20%
Patients with Schizophrenia
20%
Cognitive Deficits
20%
Set Shifting Task
20%
Cognitive Impairment
20%
Performance Deficit
20%
Procognitive
20%
Male Rats
20%
Circuitry
20%
Pathophysiology
20%
Intradimensional
20%
Sensitive Periods of Development
20%
Neural Systems
20%
Neuroscience
Nicotinic Agonist
100%
Hippocampus
100%
Behavior (Neuroscience)
100%
Tetrodotoxin
83%
Cognitive Disorder
33%
Nicotinic Acetylcholine Receptor
33%
Prefrontal Cortex
33%
Parasympathomimetic Drug
33%
Nucleus Accumbens
33%
Cognitive Effect
16%
Neural System
16%